Carlos Ferre-Aracil

4PUBLICATIONS
26CO-AUTHORS
HaematologyAutoimmunityDisease surveillanceHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|May 29, 2024
Rituximab is a safe and effective alternative treatment for patients with autoimmune hepatitis: Results from the ColHai registry.

Mar Riveiro-Barciela, Ana Barreira-Díaz, Paula Esteban

|Jan 10, 2023
Budesonide as first-line treatment in patients with autoimmune hepatitis seems inferior to standard predniso(lo)ne administration.

Álvaro Díaz-González, Manuel Hernández-Guerra, Indhira Pérez-Medrano

|Jul 29, 2021
Non-malignant portal vein thrombosis in a cohort of cirrhotic patients: Incidence and risk factors.

Marta Lopez-Gomez, Elba Llop, Angela Puente

|Aug 30, 2020
Tacrolimus as an Effective and Durable Second-Line Treatment for Chronic Autoimmune Hepatitis: A Multicentric Study.

Carlos Ferre-Aracil, Mar Riveiro-Barciela, María Trapero-Marugán

Pageof 1